A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)

NCT07463820 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

270

Enrollment

NIH

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
BIOLOGICAL: Emavusertib
BIOLOGICAL: Epoetin Alfa
BIOLOGICAL: Luspatercept

Sponsor

National Cancer Institute (NCI)